Good momentum is created by the Earnings positive surprise and the fact that OLED has increased its dividend by 16.7%.
Gross Margin of 78% and Net Margin of 34% on double-digit revenue growth speak loud of a possible higher valuation estimated by analysts.
Adjust your size accordingly. #notfinancialadvise
LNTH recently purchased cancer drugs license which are in the Phase 1 with FDA, that look promising. The company raised some cash through senior convertible notes. Quarterly revenue grew 134% YoY to $239.3mm, driven by strengths across the portfolio.
Management raised Q4 and FY22 guidance to the upside from the top-bottom lines. Last ER looks like: Lantheus...
